Myovant Sciences Ltd 's ability to collect accounts receivable sequentially worsen to 11.43, indicating more challenging environment then in the second quarter 2022, but still, it is a far cry from any concerns. Myovant Sciences Ltd 's Accounts Receivable average collection period in the Dec 31 2022 quarter, has increased to 32 days, from 30 days, in the Sep 30 2022 quarter.

If we take a look into Healthcare sector 120 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2022 from 1484 to 1500.

What is Receivable Turnover Ratio?
What is Myovant Sciences Ltd Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

MYOV Receivables Turnover Ratio	(Dec 31 2022) III. Quarter	(Sep 30 2022) II. Quarter	(Jun 30 2022) I. Quarter	(Mar 31 2022) IV. Quarter	(Dec 31 2021) III. Quarter
Y / Y Receivable Change	126.2 %	140.97 %	183.8 %	568.8 %	-
Y / Y Revenue Change	84.11 %	34.56 %	183.69 %	133.96 %	3847.79 %
Receivable Turnover Ratio (TTM)	11.43	12.33	13.95	13.52	16.49
MYOV's Total Ranking	# 1500	# 1484	# 1484	# 1484	# 1484
Accounts Receivable average collection period days	32	30	26	27	22
Seq. Receivable Change	26.83 %	15.28 %	26.09 %	22.69 %	35.12 %
Seq. Revenue Change	-4.38 %	-10.02 %	102.36 %	5.74 %	-30.12 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 27
Healthcare Sector	# 121
Overall Market	# 1500

Receivable Turnover Ratio Statistics
High	Average	Low
0.81	0.48	0.2
(Dec 31 2022)		(Sep 30 2021)

MYOV Company Profile • Back to MYOV Efficiency Comparisons • Compare MYOV Receivables Turnover Ratio to its Competitors

Financial Statements
Myovant Sciences Ltd 's Accounts Receivable	$ 44 Millions	Visit MYOV's Balance sheet
Myovant Sciences Ltd 's Sales TTM	$ 379 Millions	Visit MYOV's Income Statement
Sources of MYOV's Revenues		Visit MYOV's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
MYOV's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
MYOV's Growth Rates	MYOV's Roa	MYOV's Inventory Turnover Ratio	MYOV's Dividend Comparisons
MYOV's Profitability Ratios	MYOV's Roi	MYOV's Asset Turnover Ratio	MYOV's Dividend Growth
MYOV's Valuation Ratios	MYOV's Roe	MYOV's Financial Strength Ratios	MYOV's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2022, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2022	Receivable at quarter ending Dec 31 2022
Ainos Inc	23.40	$ 3.520 Millions	$ 0.150 Millions
Clearside Biomedical Inc	21.58	$ 1.327 Millions	$ 0.062 Millions
Catalyst Pharmaceuticals Inc	21.47	$ 214.203 Millions	$ 9.979 Millions
Argenx Se	20.93	$ 856.013 Millions	$ 40.894 Millions
Vivos Therapeutics Inc	20.57	$ 16.024 Millions	$ 0.779 Millions
Lftd Partners Inc	20.33	$ 57.417 Millions	$ 2.824 Millions
Electrocore Inc	20.17	$ 8.592 Millions	$ 0.426 Millions
Aesthetic Medical International Holdings Group Limited	19.68	$ 99.509 Millions	$ 5.056 Millions
Cv Sciences Inc	19.40	$ 16.205 Millions	$ 0.836 Millions
Immunogen inc	19.36	$ 108.782 Millions	$ 5.620 Millions
Thorne Healthtech Inc	19.32	$ 228.731 Millions	$ 11.842 Millions
C4 Therapeutics Inc	19.31	$ 31.096 Millions	$ 1.611 Millions
Sangamo Therapeutics Inc	19.27	$ 111.299 Millions	$ 5.776 Millions
Silence Therapeutics Plc	19.13	$ 17.501 Millions	$ 0.915 Millions
Nutriband Inc	18.94	$ 2.080 Millions	$ 0.110 Millions
Valion Bio Inc	18.78	$ 1.840 Millions	$ 0.098 Millions
Crispr Therapeutics Ag	18.57	$ 1.198 Millions	$ 0.065 Millions
Emmaus Life Sciences Inc	18.21	$ 18.390 Millions	$ 1.010 Millions
Arvinas Inc	17.76	$ 131.400 Millions	$ 7.400 Millions
Biomerica Inc	17.32	$ 16.082 Millions	$ 0.929 Millions
Zomedica Corp	17.15	$ 18.930 Millions	$ 1.104 Millions
Eton Pharmaceuticals Inc	17.07	$ 21.251 Millions	$ 1.245 Millions
Intellia Therapeutics Inc	16.75	$ 52.121 Millions	$ 3.112 Millions
Innovage Holding Corp	16.71	$ 688.894 Millions	$ 41.234 Millions
Chemed Corporation	16.58	$ 2,134.963 Millions	$ 128.736 Millions
Voyager Therapeutics Inc	16.36	$ 40.907 Millions	$ 2.500 Millions
U s Stem Cell Inc	16.32	$ 0.082 Millions	$ 0.005 Millions
Centogene N v	16.31	$ 53.170 Millions	$ 3.260 Millions
Wearable Health Solutions, Inc.	16.29	$ 0.853 Millions	$ 0.052 Millions
Hcw Biologics Inc	16.07	$ 6.722 Millions	$ 0.418 Millions

Date modified: 2026-08-29T17:37:43+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.